Copy and paste this code to insert a reference to this article in your
blog or online community profile:
Multiplex LCMS Bioanalysis of Brentuximab Vedotin, Rituximab and Cetuximab towards Therapeutic Drug Monitoring Application by Combined Calibration Curve Using Fab-Selective Limited Proteolysis nSMOL
Clin Pharmacol Biopharm 2016, 5:164. 5:4, (2016)
https://doi.org/10.4172/2167-065X.1000164
Highlight
Will Display Like this:
Multiplex LCMS Bioanalysis of Brentuximab Vedotin, Rituximab and Cetuximab towards Therapeutic Drug Monitoring Application by Combined Calibration Curve Using Fab-Selective Limited Proteolysis nSMOL
Clin Pharmacol Biopharm 2016, 5:164. 5:4, (2016)
https://doi.org/10.4172/2167-065X.1000164
Powered by
OMICS International